{"id":"W4407034836","doi":"10.51731/cjht.2025.1069","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Drug; Vial; Chemotherapy; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Cancer; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006202497,0.0001738811,0.0002656841,0.0007105888,0.0001827942,0.0006157004,0.0002382267,0.000256224,0.004560437],"category_scores_gemma":[0.001161739,0.00006323269,0.0003566198,0.0007527651,0.0001473258,0.0004087211,0.0002261504,0.0004983812,0.0006926602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001483723,"about_ca_system_score_gemma":0.001641738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01364744,"about_ca_topic_score_gemma":0.05080054,"domain_scores_codex":[0.9996731,0.00007150441,0.00003659483,0.00003741644,0.0001449443,0.00003641838],"domain_scores_gemma":[0.9996566,0.0000844508,0.0001082345,0.000009245957,0.0001092719,0.0000322936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003945545,0.0000399444,0.0007585434,0.005246465,0.0001856054,0.0001046646,0.0000292549,0.000128007,0.001768562,0.001600229,0.02956454,0.9601796],"study_design_scores_gemma":[0.0004259801,0.0006491656,0.009122583,0.006218374,0.0006139416,0.001280895,0.00006272514,0.0001198644,0.002720634,0.000633574,0.9781366,0.00001570291],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.008668659,0.951748,0.0006155885,0.003187251,0.0003716661,0.0001416105,0.0009942621,0.00006249648,0.03421051],"genre_scores_gemma":[0.1429143,0.8333194,0.002784086,0.003161197,0.0002940269,0.0001615354,0.001316074,0.00001291317,0.01603655],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01364744,"threshold_uncertainty_score":0.02713603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02029825038199111,"score_gpt":0.3033863679924924,"score_spread":0.2830881176105012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}